Collaborations greatly accelerate the pace of drug development. For instance, partnerships between academic researchers and pharmaceutical companies can expedite the translation of laboratory findings into clinical applications. An example is the collaboration between the University of California, San Francisco (UCSF), and Genentech, which led to the development of effective therapies for breast cancer. Collaborative efforts also help in sharing the high costs and risks associated with drug development, making it more sustainable.
